Pharmabiz16h
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis
Abbott introduces Navitor Vision in India, the next generation of heart valve technology designed to treat aortic stenosis: Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hr ...
expresshealthcare2d
Abbott launches Navitor Vision Valve in India for high-risk aortic stenosis patients
Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic ...
health.economictimes.indiatimes2d
Abbott launches Navitor Vision Valve to advance treatment of Aortic Stenosis
The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...
Is There More Upside For ABT Stock After A 10% Jump In A Week?
The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...
Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market
Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus ...
Business Wire1mon
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development
Hughes, PhD, Chairperson and Chief Executive Officer of Navitor Pharmaceuticals, to its Board of Directors, as well as Richard A. Fisher, PhD, as Chief Scientific Officer, Jim Luterman ...